Grey matter OPCs are less mature and less sensitive to IFNγ than white matter OPCs: consequences for remyelination

Sci Rep. 2018 Feb 1;8(1):2113. doi: 10.1038/s41598-018-19934-6.

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease characterized by the formation of demyelinated lesions in the central nervous system. At later stages of the disease repair in the form of remyelination often fails, which leads to axonal degeneration and neurological disability. For the regeneration of myelin, oligodendrocyte progenitor cells (OPCs) have to migrate, proliferate and differentiate into remyelinating oligodendrocytes. Remyelination occurs faster and is more extensive in grey matter (GM) lesions than in white matter (WM) lesions. Here, we examined differences in neonatal OPCs from GM (gmOPCs) and WM (wmOPCs), both intrinsically and in response to environmental (injury) signals. We show that gmOPCs are less mature than wmOPCs, both on morphological and on gene-expression level. Additionally, gmOPCs proliferate more and differentiate slower than wmOPCs. When exposed to astrocyte-secreted signals wmOPC, but not gmOPC, migration decreases. In addition, wmOPCs are more sensitive to the detrimental effects of IFNγ treatment on proliferation, differentiation, and process arborisation, which is potentiated by TNFα. Our results demonstrate that OPCs from GM and WM differ both intrinsically and in response to their environment, which may contribute to the difference in remyelination efficiency between GM and WM MS lesions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Gray Matter / cytology*
  • Gray Matter / drug effects
  • Interferon-gamma / pharmacology*
  • Nerve Regeneration / drug effects*
  • Oligodendroglia / cytology*
  • Oligodendroglia / drug effects
  • Rats
  • Remyelination / drug effects
  • Remyelination / physiology*
  • Stem Cells / cytology*
  • Stem Cells / drug effects
  • White Matter / cytology*
  • White Matter / drug effects

Substances

  • Antiviral Agents
  • Interferon-gamma